TTAB Oppositions 91274501
USPTO Oppositions proceeding 91274501, filed 2022-02-14. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91274501 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2022-02-14 |
| Last Activity | 2024-10-21 |
| Days Active | 1551 |
Parties
- Biocytogen Pharmaceuticals (Beijing) Co. — Defendant
- Genmab A/S — Plaintiff
Plaintiff Marks
Defendant Marks
- RENMAB — Biocytogen Pharmaceuticals (Beijing) Co.
Recent Documents
- 2024-10-21: TERMINATED — Status
- 2024-10-21: BD DECISION: OPP DISMISSED — Decisions
- 2024-10-11: D RESP TO BD ORDER/INQUIRY — Miscellaneous
- 2024-09-11: RESPONSE DUE 30 DAYS (DUE DATE) — Scheduling
- 2024-09-03: MOT TO AMEND APPLICATION — Motions
- 2024-06-11: REQ FOR PROG ON SETTL - SUSPENDED — Status
- 2024-06-07: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2024-06-03: TRIAL DATES REMAIN AS SET — Scheduling
- 2024-05-28: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2024-05-22: PROCEEDINGS RESUMED — Status
- 2024-04-09: SUSPENDED — Status
- 2024-02-14: MOT TO AMEND APPLICATION — Motions
- 2023-11-16: EXTENSION OF TIME GRANTED — Extensions
- 2023-11-16: P MOT FOR EXT W/ CONSENT — Motions
- 2023-08-21: EXTENSION OF TIME GRANTED — Extensions
- 2023-08-21: P MOT FOR EXT W/ CONSENT — Motions
- 2023-05-15: EXTENSION OF TIME GRANTED — Extensions
- 2023-05-15: P MOT FOR EXT W/ CONSENT — Motions
- 2023-03-14: SUSPENDED — Status
- 2023-03-14: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-12-19: SUSPENDED — Status
- 2022-12-19: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-09-21: SUSPENDED — Status
- 2022-09-21: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-07-14: EXTENSION OF TIME GRANTED — Extensions
- 2022-07-14: P MOT FOR EXT W/ CONSENT — Motions
- 2022-04-20: SUSPENDED — Status
- 2022-04-20: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-03-28: ANSWER — Pleadings
- 2022-02-14: INSTITUTED — Status